Ana səhifə

Lisbon Fire Department Standard Operating Guidelines and Policies


Yüklə 5.23 Mb.
səhifə9/40
tarix26.06.2016
ölçüsü5.23 Mb.
1   ...   5   6   7   8   9   10   11   12   ...   40


DRUG PROFILE


Initial Date: 11/01/01

Last Review/Revision: 11/08

Profile Number: 001

Service Director’s Signature





Medical Director’s Signature




The following is the basic information and guideline for use of:



ADENOSINE

Approved for use by:

EMT

Advanced EMT


EMT-Intermediate

Paramedic












XX

XX


DRUG ACTION:

Blocks the AV node to slow conduction and treat reentry conditions (tachyarrhythmias)


INDICATIONS FOR USE

Symptomatic supraventricular tachycardia


CONTRAINDICATIONS

Allergy to the drug

Heart block

Drug-induced tachycardias (e.g. from cocaine)

Atrial Flutter and Atrial Fibrillation
SIDE EFFECTS

Headache


Facial flushing

Chest pressure

Nausea
SPECIAL NOTES:

Very short duration of action, must enter the circulation and get to the heart within 10-20

seconds

Pregnancy category C


USUAL DOSE

Adult: 6 mg IV bolus followed by 10-20 ml flush; second dose 12 mg IV bolus followed by flush

Pediatric: 0.1 mg/kg IV bolus followed by a 10-20 ml flush, maximum of 6 mg; second dose 0.2

mg/kg followed by flush, maximum 12 mg


MONITOR, REPORT, DOCUMENT

Continuous ECG

Attempt to capture conversion on ECG paper

Vital signs before and within 5 minutes after administration.


END

DRUG PROFILE




Initial Date: 11/01/01

Last Review/Revision: 11/08

Profile Number: 002

Service Director’s Signature




Medical Director’s Signature




The following is the basic information and guideline for use of:


ALBUTEROL

Approved for use by:

EMT

Advanced EMT


EMT-Intermediate

Paramedic






XX

XX

XX

XX


DRUG ACTION:

Bronchodilator




INDICATIONS FOR USE

Acute bronchospasm (asthma, COPD)



CONTRAINDICATIONS

Allergy to the drug



SIDE EFFECTS

Headache


Tachycardia

Hypertension



SPECIAL NOTES:

Monitor patients with cardiovascular disease

Pregnancy category C

USUAL DOSE

Adult and Pediatric: 2.5 mg (O.5 ml) nebulized with 2.5 ml saline (total of 3 ml)



MONITOR, REPORT, DOCUMENT

Monitor ECG in patients with cardiac history or over age 45

Vital signs within 5 minutes of administration and at completion of treatment
END

DRUG PROFILE




Initial Date: 11/01/01

Last Review/Revision: 11/08

Profile Number: 003

Service Director’s Signature




Medical Director’s Signature




The following is the basic information and guideline for use of:


AMIODARONE


Approved for use by:

EMT

Advanced EMT


EMT-Intermediate

Paramedic












XX - bolus only

XX


DRUG ACTION:

Antiarrhythmic


INDICATIONS FOR USE:

Ventricular tachycardia, ventricular fibrillation {Intermediate and Paramedic}

Wide complex Atrial Fib/Flutter (ie greater than 160 bpm) {Paramedic only – on line medical control}
CONTRAINDICATIONS:

Allergy to the drug

Heart block

Bradycardia

Neonates, infants

Known or suspected drug-induced dysrhythmia (e.g. from cocaine)

Cyclic drug usage
SIDE EFFECTS:

Bradycardia

Hypotension

Congestive heart failure

Heart block
SPECIAL NOTES:

Pregnancy category D


USUAL DOSE:
300 mg IVP for ventricular fibrillation or pulseless ventricular tachycardia (may repeat 150mg IVP once in 3-5 minutes if needed)
150 mg IV bolus over 10 minute period for stable ventricular tachycardia (consider dilution in 250 ml or less of NS and run piggyback IV drip for ease of administration)
1 mg/min drip for maintenance
Pediatric: 5 mg/kg


MONITOR, REPORT, DOCUMENT

Continuous ECG


Vital signs within 5 minutes before and after administration


END
DRUG PROFILE



Initial Date: 11/01/01

Last Review/Revision: 11/08

Profile Number: 004

Service Director’s Signature




Medical Director’s Signature




The following is the basic information and guideline for use of:


ASPIRIN (ACETYLSALICYLIC ACID, ASA)


Approved for use by:

EMT

Advanced EMT


EMT-Intermediate

Paramedic






XX

XX

XX

XX

DRUG ACTION:

Anti-inflammatory

Relieves fever

Impedes blood clotting



INDICATIONS FOR USE

Given to patients with signs/symptoms of ischemic chest pain (suspected myocardial infarction)


CONTRAINDICATIONS

Allergy to the drug

Bleeding disorders

Affirmative answer to any question in the special note section below.

(Note: Should not be given to children with fever associated with acute viral illness – Reye’s Syndrome)
SIDE EFFECTS

Nausea


Gastrointestinal bleeding

Rash


Tinnitus
SPECIAL NOTES:

Low doses are more effective for anti-clotting effect

Ask patient:

Have you taken any aspirin already today?

Are you allergic to aspirin?

Do you have any bleeding disorder?

Pregnancy category D
USUAL DOSE

162-324 mg chewable tables (2-4 baby aspirin)


MONITOR, REPORT, DOCUMENT
Vital signs within 5 minutes after administration


END

DRUG PROFILE




Initial Date: 11/01/01

Last Review/Revision:: 11/08

Profile Number: 005

Service Director’s Signature




Medical Director’s Signature




The following is the basic information and guideline for use of:


ATROPINE

Approved for use by:

EMT

Advanced EMT

EMT-Intermediate


Paramedic












XX

XX



DRUG ACTION:

Block the effects of the vagus nerve (blocks parasympathetic nerve)


INDICATIONS FOR USE

Symptomatic bradycardia, heart blocks, asystole (adults), Pulseless electrical activity with a slow rate

Organophosphate poisoning
CONTRAINDICATIONS

Allergy to the drug

Glaucoma

Heart Blocks with QRS complexes greater than 0.12 mm


SIDE EFFECTS

Palpitations

Tachycardia

Blurred vision

Dry mouth

Elevated blood pressure


SPECIAL NOTES:

Pregnancy category C


USUAL DOSE

Adults: 0.5-1 mg for cardiac; 2-3 mg for organophosphate poisoning

Pediatric: 0.02 mg/kg (for rhythms associated with activities causing increased vagal tone)

Minimum dose 0.1 mg


MONITOR, REPORT, DOCUMENT

Pulse rate before and after administration

Vital signs within 5 minutes after administration

Continuous ECG


END

DRUG PROFILE



Initial Date: 11/01/01

Last Review/Revision:: 11/08

Profile Number: 006

Service Director’s Signature




Medical Director’s Signature



The following is the basic information and guideline for use of:



DEXTROSE


Approved for use by:

EMT

Advanced EMT


EMT-Intermediate

Paramedic






Oral only

XX

XX

XX


DRUG ACTION:

Provides calories for metabolic needs



INDICATIONS FOR USE

Hypoglycemia


CONTRAINDICATIONS

Increased intracranial pressure

Alcoholic in delirium tremors

SIDE EFFECTS

Hyperglycemia

SPECIAL NOTES:

Will cause tissue sloughing if infiltrated

Must be diluted before administration to children

Especially in children, IM Glucagon should be considered prior to attempting peripheral IV and IV Dextrose.

Consider Thiamine in malnourished or suspected alcoholics

USUAL DOSE:


  • In the patient greater than100 pounds with an altered level of consciousness, who is unable to safely take oral glucose and with a blood glucose level less than 60 mg/dL, administer 25 grams Dextrose IV bolus.

  • In the patient less than100 pounds but at least 2 years old, Glucagon IM should be considered prior to attempting an IV and giving Dextrose. If Dextrose is indicated, administer 500 mg/kg (0.5 grams/kg) Dextrose diluted 1:1 with NS. Draw up the dose calculated into a large syringe and dilute (draw into the same syringe) with an equal volume of NS. For patients younger than 2 years, contact medical control for appropriate dose and dilution of dextrose (deleted reference to ml/kg).

  • In the patient who can safely eat or drink, oral glucose (Glutose) replacement is preferred.

  • Instruct patient that the gel must be swallowed

  • Allow patient to self-administer gel incrementally or assist with squeezing gel into patient’s mouth incrementally.

  • Repeat as necessary until you arrive at the hospital or mental status is normal and blood sugar is equal to or greater than 80 mg/dL.

  • If the patient is not responding to oral glucose and blood sugar continues to be low, consider IV dextrose administration.

  • For patients in whom an IV cannot be established:

  • For patients who weigh more than 44 pounds, administer 1 mg Glucagon IM (see drug profile # 011).
  • For pediatric patients (less than 44 pounds) administer 0.5 mg Glucagon IM (See drug profile # 011)

MONITOR, REPORT, DOCUMENT

Changes in level of consciousness

Blood sugar before and after treatment

Vital signs within 5 minutes after administration

Watch carefully for infiltration

END

DRUG PROFILE




Initial Date: 11/01/01

Last Review/Revision:: 11/08

Profile Number: 007

Service Director’s Signature




Medical Director’s Signature




The following is the basic information and guideline for use of:


DIAZEPAM (VALIUM)

Approved for use by:

EMT

Advanced EMT


EMT-Intermediate

Paramedic












XX – For Seizures only

XX



DRUG ACTION:

Central nervous system depressant

Muscle relaxant

INDICATIONS FOR USE

Continuous or recurrent seizures, status epilepticus

Sedation for procedures
CONTRAINDICATIONS

Allergy to the drug

Hypotension

Altered level of consciousness

Intoxication
SIDE EFFECTS

Hypotension

Rash

Respiratory depression



Bradycardia
SPECIAL NOTES:

Controlled substance (federal regulations), addictive

Pregnancy category D
USUAL DOSE

Adult: 2-5 mg IV, (rectally if unable to establish an IV line)

Pediatric: 0.05-0.1 mg/kg IV, maximum of 8 mg.

0.5 mg/kg rectally, maximum of 20 mg [Can use an equal dose of Diastat (rectal diazepam gel)]


MONITOR, REPORT, DOCUMENT

Vital signs and respiratory assessment within 5 minutes after administration

Altered level of consciousness

Seizure activity



END
DRUG PROFILE


Initial Date: 11/01/01

Last Review/Revision:: 11/08

Profile Number: 008

Service Director’s Signature




Medical Director’s Signature




The following is the basic information and guideline for use of:


DIPHENHYDRAMINE (BENADRYL)

Approved for use by:

EMT

Advanced EMT


EMT-Intermediate

Paramedic















XX



DRUG ACTION:

Antihistamine, blocks histamine’s effect on smooth muscle in the respiratory, circulatory and gastrointestinal systems. Histamine causes bronchoconstriction, vasodilation and GI spasms


INDICATIONS FOR USE

Allergic reactions


CONTRAINDICATIONS

Allergy to drug

Glaucoma

Newborns
SIDE EFFECTS

Drowsiness, confusion

Seizures


Tachycardia

Blurred vision

Nausea, vomiting
SPECIAL NOTES:

Pregnancy category B


USUAL DOSE

12 and older: 25-50 mg IV or PO

Younger than 12 years old: 1.25 mg/kg, maximum of 25 mg IV or PO
MONITOR, REPORT, DOCUMENT

Vital signs within 5 minutes after administration


END
DRUG PROFILE

Initial Date: 11/01/01

Last Review/Revision: 11/08

Profile Number: 009

Service Director’s Signature




Medical Director’s Signature



The following is the basic information and guideline for use of:



EPINEPHRINE (ADRENALIN)

Approved for use by:

EMT

Advanced EMT


EMT-Intermediate

Paramedic






XX (IM 1:1,000) for anaphylaxis*

XX (IM 1:1000) for anaphylaxis

XX

XX

*Requires Operational Plan if not using auto-injector
DRUG ACTION:

Increases heart rate and force

Vasoconstriction

Bronchodilation



INDICATIONS FOR USE

Asthma (1:1000 IM) (EMT-Intermediate and Paramedic only)

Anaphylaxis (1:1000 IM)

Patients in cardiopulmonary arrest while CPR is in progress (IV bolus 1:10,000) (Intermediate and Paramedic only)


CONTRAINDICATIONS

Glaucoma


Shock other than anaphylactic
SIDE EFFECTS

Headache


Palpitations

Hypertension

Tachycardia
SPECIAL NOTES:

Don’t mix with alkaline solutions (sodium bicarbonate)

Epi-Pen = 0.3 mg

Epi-Pen Jr. = 0.15 mg (less than 60 pounds)

Pregnancy category C
USUAL DOSE

IM dose (1:1,000) (1 mg in 1 ml)

0.1-0.3mg 1:1000 for anaphylaxis. For asthma (Intermediate and Paramedic use only),

May repeat in 5 minutes if no improvement or worsening of condition with medical control

approval

IV/IO dose (1:10,000) (1 mg in 10 ml) Cardiopulmonary arrest

Adult: 1 mg IV/IO, 2 mg ET

Pediatrics less than 60 pounds:

0.01 mg/kg dose, 0.1 mg/kg ET dose

MONITOR, REPORT, DOCUMENT

Breath sounds, vital signs within 5 minutes after administration

Effect on heart rate

Continuous ECG monitoring


END

DRUG PROFILE




Initial Date: 11/01/01

Last Review/Revision: 11/08

Profile Number: 010

Service Director’s Signature




Medical Director’s Signature




The following is the basic information and guideline for use of:


FUROSEMIDE (LASIX)


Approved for use by:

EMT

Advanced EMT


EMT-Intermediate

Paramedic












XX

XX



DRUG ACTION:

Diuretic
INDICATIONS FOR USE

Not recommended for routine pre-hospital treatment of acute congestive heart failure/pulmonary edema unless diagnosis of CHF/pulmonary edema confirmed
CONTRAINDICATIONS

Allergy to the drug

Anuria (no urine output, e.g. dialysis patient)

Hypotension (Systolic BP less than 90 mmHg)


SIDE EFFECTS

Hypotension

Rash
SPECIAL NOTES:

Long term use can result in electrolyte imbalance and dehydration

Use with caution in patients with allergy to sulfa drugs

Pregnancy category C


USUAL DOSE

40 mg IV bolus


MONITOR, REPORT, DOCUMENT

Daily maintenance dose

Vital signs, respiratory assessment within 5 minutes after administration

Any urinary output


END

DRUG PROFILE




Initial Date: 11/01/01

Last Review/Revision: 12/08

Profile Number: 011

Service Director’s Signature




Medical Director’s Signature



The following is the basic information and guideline for use of:



GLUCAGON

Approved for use by:

EMT

Advanced EMT


EMT-Intermediate

Paramedic






XX **optional**

XX

XX

XX


DRUG ACTION:

Raises blood glucose by stimulating liver to release stored glycogen (sugar) and converting fats and proteins to glucose



INDICATIONS FOR USE

Hypoglycemia


CONTRAINDICATIONS

Allergy to the drug

History of pheochromocytoma (tumor which secretes epinephrine)
SIDE EFFECTS

Hypotension

Nausea, vomiting

Respiratory distress


SPECIAL NOTES:

May be repeated in 20 minutes if no response. IV glucose must be given if patient doesn’t respond to glucagon.

Drug is supplied in a powdered form and must be reconstituted in the solution supplied with the powder.

Patient needs to eat carbohydrates as soon as awake and able to swallow safely.

In the pediatric patient, IM Glucagon should be administered prior to attempting peripheral IV and IV Dextrose.

Pregnancy category B


USUAL DOSE

In the patient who can safely eat or drink, oral glucose replacement is preferred.

Instruct patient that the gel must be swallowed

Allow patient to self-administer gel incrementally or assist with squeezing gel into patient’s mouth incrementally.

Repeat as necessary until tube content has been consumed.
For patients in whom an IV cannot be established:

For patients who weigh more than 44 pounds, administer 1 mg Glucagon IM.


For pediatric patients (less than 44 pounds) administer 0.5 mg Glucagon IM
Intranasal dosing same as above IM dosing


MONITOR, REPORT, DOCUMENT

Vital signs within 5 minutes after administration


Changes in level of consciousness
Blood sugar before and after administration


END

DRUG PROFILE




Initial Date: 11/01/01

Last Review/Revision:: 11/08

Profile Number: 012

Service Director’s Signature




Medical Director’s Signature




The following is the basic information and guideline for use of:

LIDOCAINE

Approved for use by:

EMT

Advanced EMT


EMT-Intermediate

Paramedic












XX-bolus only

XX


DRUG ACTION:

Antiarrhythmic (ventricular)


INDICATIONS FOR USE

Ventricular arrhythmias (PVCs, ventricular tachycardia, ventricular fibrillation)

Local and bone marrow anesthetic for placement of IO line
CONTRAINDICATIONS

Allergy to this or other “caine” drug

Heart blocks
SIDE EFFECTS

Seizures


Hypotension

Bradycardia


SPECIAL NOTES:

If allergic to other local anesthetics (e.g. Novocain), contact medical control prior to administration

Pregnancy category B
USUAL DOSE

1-1.5 mg/kg IV, maximum dose 3 mg/kg

2-4 mg/min maintenance dose

For IO placement:

0.5-1 ml 2% solution infiltrated subcutaneously at IO site

Adult: 20-40 mg (1-2 ml) of 2% Lidocaine IO bolus over one minute

Pediatric: 0.5 mg/kg of 2% Lidocaine IO bolus

Note: 2% Lidocaine = 20 mg/ml
MONITOR, REPORT, DOCUMENT

Continuous ECG

Vital signs within 5 minutes after administration
END
DRUG PROFILE


Initial Date: 11/01/01

Last Review/Revision:: 11/08

Profile Number: 013

Service Director’s Signature




Medical Director’s Signature



The following is the basic information and guideline for use of:


MORPHINE SULFATE

Approved for use by:

EMT

Advanced EMT


EMT-Intermediate

Paramedic












XX

XX



DRUG ACTION:

Long acting narcotic analgesic (pain relief)

Central nervous system depressant
INDICATIONS FOR USE

Chest pain of cardiac origin

Burns (moderate to severe pain)

Extremity trauma (moderate to severe pain)

Contact medical control prior to any other use
CONTRAINDICATIONS

Allergy to the drug

Hypotension

Head, chest, abdominal trauma

Respiratory depression
SIDE EFFECTS

Decreased level of consciousness

Bradycardia

Hypotension

Nausea, vomiting

Respiratory depression


SPECIAL NOTES:

Addictive, federal regulations apply

Can be reversed with naloxone (see drug profile 014)

Pregnancy category C (D in long-term use or high dose)


USUAL DOSE

2-5 mg slow IV bolus over 2-3 minutes, may be repeated for severe pain (adult)

0.05 mg/kg (pediatric)
MONITOR, REPORT, DOCUMENT

Effect on pain level

Effect on respiratory rate and effort

Vital signs within 5 minutes after administration



END

DRUG PROFILE




Initial Date: 11/01/01

Last Review/Revision: 11/08

Profile Number: 014

Service Director’s Signature




Medical Director’s Signature



The following is the basic information and guideline for use of:


NALOXONE (NARCAN)

Approved for use by:

EMT

Advanced EMT


EMT-Intermediate

Paramedic









XX

XX

XX



DRUG ACTION:

Reverses narcotic-induced respiratory depression and altered level of consciousness


INDICATIONS FOR USE

Suspected narcotic overdose in patients with altered level of consciousness


CONTRAINDICATIONS

Allergy to the drug


SIDE EFFECTS

Tremors

Tachycardia


Nausea, vomiting
SPECIAL NOTES:

May induce narcotic withdrawal in addicts (Nausea, vomiting, diaphoresis, tachycardia, hypertension)

Duration of action of naloxone may be shorter than the narcotic and the patient may relapse

Consider contact of Poison Control (1-800-222-1222).

Pregnancy category C

USUAL DOSE

Adults: 0.4 – 2 mg slow IV, IM, repeated in 2-3 minutes

Pediatric: 0.01 mg/kg first dose; 0.1 mg/kg second and subsequent doses, maximum dose 2 mg

Intranasal dose same as IV/IM dosing


MONITOR, REPORT, DOCUMENT
Changes in level of consciousness

Vital signs within 5 minutes after administration
END
DRUG PROFILE


Initial Date: 11/01/01

Last Review/Revision:: 11/08

Profile Number: 015

Service Director’s Signature




Medical Director’s Signature



The following is the basic information and guideline for use of:


NITROGLYCERIN

Approved for use by:

EMT

Advanced EMT


EMT-Intermediate

Paramedic






XX (Patient assisted) *

XX

XX

XX

*Requires Operational Plan
DRUG ACTION:

Vasodilator

Decreases venous return
INDICATIONS FOR USE

Chest pain of cardiac origin (ischemic), angina

Acute congestive heart failure
CONTRAINDICATIONS

Hypotension (systolic pressure less than 100 mm/Hg)

Use of sildenafil (Viagra) within the past 24 hours

Use of tadalafil (Cialis) or vardenafil (Levitra) within past 48 hours


SIDE EFFECTS

Headache


Hypotension (systolic pressure less than 100 mm/Hg)

Tachycardia


SPECIAL NOTES:
Drug is sensitive to light and moisture
IV access should be established prior to administration of nitroglycerine unless vital signs are stable and you are assisting the patient in taking his/her own medication.
Pregnancy category C


USUAL DOSE

Adults: 0.4 mg sublingually, may repeat every 3-5 minutes for 15 minutes. Check with medical control for additional doses.


MONITOR, REPORT, DOCUMENT

Vital signs and pain assessment within 5 minutes after administration


Blood pressure before and after administration


END

DRUG PROFILE




Initial Date: 11/01/01

Last Review/Revision:: 11/08

Profile Number: 016

Service Director’s Signature




Medical Director’s Signature



The following is the basic information and guideline for use of:


PROCAINAMIDE

Approved for use by:

EMT

Advanced EMT


EMT-Intermediate

Paramedic















XX


DRUG ACTION:

Antiarrhythmic


INDICATIONS FOR USE

Ventricular tachycardia, ventricular fibrillation, PVCs


CONTRAINDICATIONS

Allergy to the drug

Heart block

Torsades des pointes


SIDE EFFECTS

Hypotension

Bradycardia

Heart block

Nausea, vomiting

Rash
SPECIAL NOTES:

Monitor the width of the QRS and the blood pressure

Pregnancy category C


USUAL DOSE

Adult: 50-100 mg IV bolus over 5 minute period until:

QRS is 50% wider than at start of medication administration

Maximum dose of 17 mg/kg has been given

Effect on dysrhythmia achieved

Special pediatric considerations: 15 mg/kg over 30-60 minutes only for ventricular tachycardia

with pulses
MONITOR, REPORT, DOCUMENT

QRS duration

ECG changes

Vital signs before and within 5 minutes after administration


END


DRUG PROFILE


Initial Date: 11/01/01

Last Review/Revision:: 11/08

Profile Number: 017

Service Director’s Signature




Medical Director’s Signature



The following is the basic information and guideline for use of:


SODIUM BICARBONATE

Approved for use by:

EMT

Advanced EMT


EMT-Intermediate

Paramedic















XX



DRUG ACTION:

Neutralizes acids


INDICATIONS FOR USE

Treat metabolic acidosis associated with cardiopulmonary arrest

Ventricular dysrhythmias secondary to cyclic antidepressants
CONTRAINDICATIONS

Alkalosis


SIDE EFFECTS

Alkalosis


SPECIAL NOTES:

Must be diluted for neonates

Pregnancy category C
USUAL DOSE

1 mEq/kg



MONITOR, REPORT, DOCUMENT
Changes in level of consciousness

ECG changes

Vital signs within 5 minutes after administration


END

DRUG PROFILE




Initial Date: 11/01/01

Last Review/Revision: 11/08

Profile Number: 018

Service Director’s Signature




Medical Director’s Signature



The following is the basic information and guideline for use of:


AMMONIA INHALANTS

Approved for use by:

EMT

Advanced EMT


EMT-Intermediate

Paramedic






XX

XX

XX

XX


DRUG ACTION:

Olfactory stimulant, reflex respiratory stimulant, elevates blood pressure


INDICATIONS FOR USE

Patient who presents with an altered level of consciousness after other physical causes have been ruled out.


CONTRAINDICATIONS

Patient is alert and oriented

Medical cause for the altered level of consciousness has been established
SIDE EFFECTS

Irritation of respiratory membranes, pharynx, esophagus


SPECIAL NOTES:

Rule out all medical and traumatic causes for altered level of consciousness before using ammonia inhalants

DO NOT insert ammonia inhalants into any orifice or place under oxygen mask

May irritate patient


USUAL DOSE

One capsule, broken and waved under the patient’s nose during inhalation


MONITOR, REPORT, DOCUMENT

Change in level of consciousness

Vital signs within 5 minutes after administration
END

DRUG PROFILE




Initial Date: 11/01/01

Last Review/Revision:: 11/08

Profile Number: 019

Service Director’s Signature




Medical Director’s Signature



The following is the basic information and guideline for use of:


IPRATROPIUM (ATROVENT)

Approved for use by:

EMT

Advanced EMT


EMT-Intermediate

Paramedic






XX **

XX

XX

XX

**optional**
DRUG ACTION:

Bronchodilator


INDICATIONS FOR USE

Maintenance therapy in patients with Chronic Obstructive Pulmonary Disease (COPD)


Bronchospasm


CONTRAINDICATIONS

Allergy to the drug, soybeans, peanuts

Glaucoma
SIDE EFFECTS

Dry mouth

Headache

Nausea, vomiting, cramping

Tachycardia
SPECIAL NOTES:

Most often used in combination with or immediately following albuterol

Not recommended to be used alone in acute respiratory distress

May use pre-mixed combination with Albuterol for first adult treatment (ie “Duo-Neb”)

Pregnancy category B
USUAL DOSE

0.5 mg nebulized with 2.5 ml saline (total of 3 ml)

0.25 mg nebulized for children less than 12 years of age



MONITOR, REPORT, DOCUMENT
Monitor ECG in patients with cardiac history or over age 45

Vital signs and breath sounds within 5 minutes of administration and at completion of treatment
END

DRUG PROFILE




Initial Date: 11/01/01

Last Review/Revision:: 11/08

Profile Number: 020

Service Director’s Signature




Medical Director’s Signature



The following is the basic information and guideline for use of:


VASOPRESSIN

Approved for use by:

EMT

Advanced EMT


EMT-Intermediate

Paramedic












XX

XX


DRUG ACTION:

Peripheral vasoconstriction



INDICATIONS FOR USE

Cardiac arrest patients in ventricular fibrillation, pulseless ventricular tachycardia, asystole or pulseless electrical activity (as an option in place of initial or second dose of epinephrine)



CONTRAINDICATIONS

Conscious patients with coronary artery disease

Allergy
SIDE EFFECTS

Pallor


Bronchial constriction

Uterine contraction


SPECIAL NOTES:

Vasopressin may be given in place of the 1st or 2nd dose of epinephrine (see drug profile #009) in the cardiac resuscitation protocol

Pregnancy category C
USUAL DOSE

Adults: 40 Units IV or IO, one dose only


MONITOR, REPORT, DOCUMENT
Electrocardiogram

Vital signs and breath sounds within 5 minutes of administration
END
DRUG PROFILE


Initial Date: 11/01/01

Last Review/Revision: 11/08

Profile Number: 021

Service Director’s Signature




Medical Director’s Signature



The following is the basic information and guideline for use of:


CALCIUM CHLORIDE

Approved for use by:

EMT

Advanced EMT


EMT-Intermediate

Paramedic















XX


DRUG ACTION:

Cardiac stimulant, increases force of contraction

Calcium as an element is required for many physiological activities
INDICATIONS FOR USE

Calcium channel blocker overdose

Elevated potassium (hyperkalemia)

Low calcium (hypocalcemia)




CONTRAINDICATIONS

Patient taking digitalis (Use with caution)

Ventricular tachycardia

Ventricular fibrillation




SIDE EFFECTS

Bradycardia

Arrhythmias

Syncope


Cardiac arrest
SPECIAL NOTES:

Flush line before administering sodium bicarbonate (causes precipitation)

Be sure the IV is not infiltrated, causes tissue sloughing

Pregnancy category C


USUAL DOSE

Adult: 100-500 mg IV bolus

Pediatric: 20 mg/kg, maximum dose 500 mg
MONITOR, REPORT, DOCUMENT

Continuous ECG

Vital signs before and within 5 minutes after administration
END

DRUG PROFILE



Initial Date: 11/01/01

Last Review/Revision: 11/08

Profile Number: 022

Service Director’s

Signature




Medical Director’s

Signature



The following is the basic information and guideline for use of:


THIAMINE

Approved for use by:

EMT

Advanced EMT


EMT-Intermediate

Paramedic















XX



DRUG ACTION:

Allows breakdown of Glucose


INDICATIONS FOR USE:

Alcoholic patients and those who are malnourished


CONTRAINDICATIONS:

Allergy to the drug


SIDE EFFECTS: n/a

SPECIAL NOTES:

Helpful prior to administration of glucose in alcoholic or those malnourished

Pregnancy category A
USUAL DOSE:

100 mg IVP


MONITOR, REPORT, DOCUMENT:

Vital signs before and within 5 minutes after administration


END

DRUG PROFILE




Initial Date: 11/01/01

Last Review/Revision: 1/05/09

Profile Number: 023

Service Director’s

Signature




Medical Director’s

Signature



The following is the basic information and guideline for use of:


Midazolam (Versed)

Approved for use by:

EMT

Advanced EMT


EMT-Intermediate

Paramedic















XX



DRUG ACTION:

Central nervous system depressant


INDICATIONS FOR USE:

Sedation for patients prior to intubation and cardioversion

Seizure management
CONTRAINDICATIONS:

Allergy to the drug

hypotension
SIDE EFFECTS:

Hypotension, respiratory depression, bradycardia, disinhibition resulting in agitation


SPECIAL NOTES:

Always have advanced airway equipment ready prior to use. Always preoxygenate prior to use. Can reverse with Romazicon (see drug profile 025)

Pregnancy category D
USUAL DOSE:

Adults – 2-5 mg

Maximum RSI dose 10 mg.

Seizures: 2-5 mg IV/IM (may repeat in 5 minutes) (Titrate IV bolus dose to effect)

Pediatrics – 0.05 mg/kg (not to exceed adult dose)

Seizures: 0.05 mg/kg-0.1 mg/kg IV/IM (may repeat in 5 minutes)(Titrate IV bolus

dose to effect)

Rectal Dose 0.1 mg/kg; maximum total dose 5 mg



Intranasal dose: Same as IV dose
MONITOR, REPORT, DOCUMENT:

Continuous ECG and Oxygen Saturation monitoring.

Vital signs before and within 5 minutes after administration.
END

DRUG PROFILE




Initial Date: 11/01/01

Last Review/Revision: 11/08

Profile Number: 024

Service Director’s

Signature




Medical Director’s

Signature



The following is the basic information and guideline for use of:


DOPAMINE

Approved for use by:

EMT

Advanced EMT


EMT-Intermediate

Paramedic















XX



DRUG ACTION:

Vasoconstriction

Low doses cause renal and mesenteric vasodilation

Increases force of contraction of heart to increase cardiac output


INDICATIONS FOR USE:

Hypotension not associated with hypovolemia


CONTRAINDICATIONS:

Allergy to the drug

Tachydysrhythmia

Ventricular fibrillation

Hypovolemia
SIDE EFFECTS:

Hypertension, tachydysrhythmia (dose related), increased myocardial oxygen demand


SPECIAL NOTES:

If hypotension related to hypovolemia, tachydysrhythmia are very common.

MAO’s may potentiate the effect of Dopamine

Pregnancy category C


USUAL DOSE:

Mix 400 mg in 250 cc of normal saline and titrate for effect

Typical range 5-10 mcg/kg/min

Titrate dose to BP systolic of 100 mmHg


MONITOR, REPORT, DOCUMENT:

Continuous ECG

Vital signs before and within 5 minutes after administration.
END

DRUG PROFILE




Initial Date: 11/01/01

Last Review/Revision: 11/08

Profile Number: 025

Service Director’s

Signature




Medical Director’s

Signature



The following is the basic information and guideline for use of:


Flumazenil (ROMAZICON)

Approved for use by:

EMT

Advanced EMT


EMT-Intermediate

Paramedic















XX



DRUG ACTION:

Reversal of sedative effects of benzodiazepines


INDICATIONS FOR USE:

Known pure benzodiazepine overdose, Versed reversal

To be used only with the approval of on-line medical control
CONTRAINDICATIONS:

Allergy to the drug

Cyclic antidepressant overdose, mixed overdose, dysrhythmias, wide QRS, chronic benzodiazepine use
SIDE EFFECTS:

Headache, dizziness, dysrhythmias, seizures, vomiting


SPECIAL NOTES:

Used in patients with respiratory failure secondary to pure benzodiazepine overdose.

Not to be used as part of routine unresponsive patient care. Contact medical control before administration

Pregnancy category C


USUAL DOSE:

Initial dose 0.2 mg IVP. Repeat dose to max of 1 mg if needed


MONITOR, REPORT, DOCUMENT:

Continuous ECG

Vital signs before and within 5 minutes after administration.
END

DRUG PROFILE




Initial Date: 12/05/2002

Last Review/Revision: 11/08

Profile Number: 026

Service Director’s Signature




Medical Director’s Signature



The following is the basic information and guideline for use of:



MAGNESIUM SULFATE


Approved for use by:

EMT

Advanced EMT


EMT-Intermediate

Paramedic















XX


DRUG ACTION:

Central nervous system depressant, anticonvulsant, antiarrhythmic, bronchial smooth muscle relaxant



INDICATIONS FOR USE

Obstetrical: Eclampsia

Cardiovascular: Refractory ventricular fibrillation or pulseless ventricular tachycardia, torsades

de pointes

Respiratory: Status asthmaticus
CONTRAINDICATIONS

1   ...   5   6   7   8   9   10   11   12   ...   40


Verilənlər bazası müəlliflik hüququ ilə müdafiə olunur ©atelim.com 2016
rəhbərliyinə müraciət